Lawyers investigate Talecris board over Grifols deal
This article was originally published in Scrip
Executive Summary
Law firms have begun investigating whether Talecris Biotherapeutics' board of directors breached their fiduciary duty or otherwise violated state law in agreeing to the company's acquisition by Grifols of Spain.